Upregulates growth hormone receptors, promotes angiogenesis via VEGF, modulates nitric oxide synthesis, and activates FAK/paxillin pathway for tendon fibroblast migration.
Studies have administered: 1–10mcg/kg daily in animal studies; 200–500mcg/day in human case literature
Extensive animal research showing accelerated tendon, ligament, bone, and gut healing. Limited formal human RCTs; human data primarily from case reports and retrospective studies.
Generally well-tolerated in animal studies; nausea occasionally reported in human case literature
These compounds have been examined together in research literature. Combination use is not endorsed or recommended — this information is provided for research context only.
Want a Complete Research Monograph?
Our AI can generate a 2,000+ word deep-dive on BPC-157 — including full clinical trial summaries, pharmacokinetics, and research frontiers.
Generate Deep Dive in Research Chat